ASO Author Reflections: Similar Short- and Long-Term Outcomes in Variable Use and Timing of Restaging MRI and Surgery After Preoperative Chemoradiotherapy for Rectal Cancer
- PMID: 30847749
- PMCID: PMC6901407
- DOI: 10.1245/s10434-019-07286-y
ASO Author Reflections: Similar Short- and Long-Term Outcomes in Variable Use and Timing of Restaging MRI and Surgery After Preoperative Chemoradiotherapy for Rectal Cancer
Conflict of interest statement
The authors declare that they have no conflict of interest.
Comment on
-
Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes.Ann Surg Oncol. 2019 Feb;26(2):437-448. doi: 10.1245/s10434-018-07097-7. Epub 2018 Dec 13. Ann Surg Oncol. 2019. PMID: 30547330 Free PMC article.
References
-
- Lefevre JH, Mineur L, Simon T, et al. Effect of interval (7 or 11 weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer: a multicenter, randomized, controlled trial (GRECCAR-6) J Clin Oncol. 2016;34:3773–3780. doi: 10.1200/JCO.2016.67.6049. - DOI - PubMed
-
- Beets-Tan RGH, Lambregts DMJ, Maas M, et al. Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol. 2018;28:1465. doi: 10.1007/s00330-017-5026-2. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
